Stem Cell Therapy Market By Treatment Type (Allogenic Treatment and Autologous Treatment), By Cell Source (Bone Marrow & Peripheral Blood, Adipose Tissue, Placenta & Umbilical Cord, Embryo, and Others), By Indication (Orthopaedic & Dental, Wound & Injuries, Cardiology & Neurology, Immunology and Inflammatory, Oncology & Metabolism, and Others), By Region, Trends, Analysis and Forecast till 2034

Stem Cell Therapy Market was valued at USD 8.5 Billion in 2024 and is projected to grow at a CAGR of 32.10% to reach USD 137.5 Billion by 2034.

Stem cell therapy is the treatment of various disorders or uses to treat or prevent diseases. It can prevent and treat the 80 disorders including degenerative disorder and neuromuscular. Stem cells therapy is also called as regenerative medicines treatment. There are 3 types of stem cell adult stem cells, embryonic stem cells, and induced pluripotent stem cells. Stem cells are the cells which have unique ability to replace the damaged cells and regenerate the cells and tissues.

Increasing awareness towards the therapeutics potency stem cells in giving proper treatment choices for a range of wide diseases which is the major driving factor for the growth of the stem cell therapy market. Additionally, the rising importance of regenerative medicine all over the globe and developing advanced cell therapy products based on stem cells is the boosting factor for the growth of the target market. For instance, in 2014, the NIH (National Institute of Health) at the University of California, San Diego (UCSD) Health System declared the launch of a clinical trial to evaluate the safety of neural stem cell-based therapy in patients with the chronic spinal cord injury. Moreover, by using stem cell therapy the diseases such as spinal cord injury, burns, stroke, heart diseases, macular degeneration, rheumatoid arthritis, osteoarthritis, and diabetes are treated. However, the treatment using stem cell therapy is costly, thus, the major restraining factor for the growth of the market. Nevertheless, increasing focus on the research and development of stem cells therapy can create an opportunity for the growth of the target market.

The stem cell therapy market is segmented based on treatment type, cell source, indication, and region.

Based on treatment type, the stem cell therapy market is segmented into allogenic treatment and autologous treatment. Based on the cell source, the target market is segmented into bone marrow & peripheral blood, adipose tissue, placenta & umbilical cord, embryo, and others. Based on indication, the market is classified into orthopaedic & dental, wound & injuries, cardiology & neurology, immunology and inflammatory, oncology & metabolism, and others.

Regional Insights:

Based on the region the stem cell therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the North America region is dominating the target market due to the presence of a strong investment in regenerative medicine sector and healthcare infrastructure. Additionally, the Europe region shows a significant growth in the market due to rising research and increasing the investment in the target market.  Moreover, investments into research and development for better healthcare is anticipated to create growth opportunities for the Asia Pacific stem cell therapy market.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Stem Cell Therapy Market report based on treatment type, cell source, indication, and region.

Stem Cell Therapy Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the stem cell get to market involves Osiris Therapeutics, Inc., ANTEROGEN.CO. LTD., Athersys Inc., CORESTEM, Inc., JCR Pharmaceuticals Co., Ltd., Mesoblast Ltd., NuVasive, Inc., Orthofix Holdings, Inc., Osiris Therapeutics, Inc., Reliance Life Sciences Private Limited. Prominent players operating in the target market are focusing on strategic partnerships as well as launching various treatment types to gain a competitive edge in the target market. In 2018, Osiris Therapeutics, Inc. dominated the target market, with all over-contribution 17.6% of the product of the stem cell therapy market size.

• Osiris Therapeutics, Inc.
• ANTEROGEN.CO. LTD.
• Athersys Inc.
• CORESTEM, Inc.
• JCR Pharmaceuticals Co., Ltd.
• Mesoblast Ltd.
• NuVasive, Inc.
• Orthofix Holdings, Inc.
• Osiris Therapeutics, Inc.
• Reliance Life Sciences Private Limited